NCT03894150
- Conditions
- Refractory or Recurrent CD30+ Hematologic Malignancies
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
- Henan Cancer Hospital Zhengzhou, Henan, China
Clinical trial condition
Refractory or Recurrent CD30+ Hematologic Malignancies
Explore clinical trials studying Refractory or Recurrent CD30+ Hematologic Malignancies. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies